THAR
Hillstream BioPharma Inc

3,035
Mkt Cap
$163.65M
Volume
555,548.00
52W High
$9.08
52W Low
$0.952
PE Ratio
-1.06
THAR Fundamentals
Price
$4.01
Prev Close
$4.14
Open
$4.00
50D MA
$3.04
Beta
0.84
Avg. Volume
1.06M
EPS (Annual)
-$9.41
P/B
4.85
Rev/Employee
$0.00
$0.9279
Loading...
Loading...
Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or uncontrollable itching in PBC, a rare and orphan liver disease with no known cure. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2

Frequently Asked Questions

What is Market Cap of Tharimmune Inc?
What is the 52-week high for Tharimmune Inc?
What is the 52-week low for Tharimmune Inc?
What is Tharimmune Inc stock price today?
What was Tharimmune Inc stock price yesterday?
What is the PE ratio of Tharimmune Inc?
What is the Price-to-Book ratio of Tharimmune Inc?
What is the 50-day moving average of Tharimmune Inc?
How many employees does Tharimmune Inc have?

Latest THAR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.